Newspaper article The Canadian Press

Speciality Drug Firm Concordia International Seeks to Cut Debt by $2 Billion

Newspaper article The Canadian Press

Speciality Drug Firm Concordia International Seeks to Cut Debt by $2 Billion

Article excerpt

Concordia International stock plunges

--

OAKVILLE, Ont. - Shares of Concordia International Corp. (TSX:CXR) plunged below $1 on Friday after the Ontario-based drug company announced its intention to reduce its debt by more than $2 billion under a proposed recapitalization transaction.

Concordia had traded above $100 for a time in mid-2015 before its fall. Its shares were down 35 cents or about 30 per cent at 83 cents after the announcement.

The speciality drug company is making the move under the Canada Business Corporations Act which it noted is not a bankruptcy or insolvency statute.

But Concordia says several payments to unsecured lenders will not be paid and its proposal may result in a sizable dilution of its shares, though the extent was not known at this time. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.